International Assets Investment Management LLC Makes New Investment in Koninklijke Philips (NYSE:PHG)

International Assets Investment Management LLC purchased a new stake in Koninklijke Philips (NYSE:PHG - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 40,851 shares of the technology company's stock, valued at approximately $953,000.

Other institutional investors have also made changes to their positions in the company. Allworth Financial LP raised its holdings in shares of Koninklijke Philips by 113.3% in the third quarter. Allworth Financial LP now owns 3,242 shares of the technology company's stock valued at $65,000 after buying an additional 1,722 shares during the last quarter. Spire Wealth Management increased its position in Koninklijke Philips by 127.2% in the third quarter. Spire Wealth Management now owns 3,446 shares of the technology company's stock worth $69,000 after purchasing an additional 1,929 shares during the period. Bruce G. Allen Investments LLC acquired a new stake in Koninklijke Philips in the fourth quarter worth about $140,000. PAX Financial Group LLC acquired a new stake in Koninklijke Philips in the third quarter worth about $199,000. Finally, Contravisory Investment Management Inc. acquired a new stake in Koninklijke Philips in the fourth quarter worth about $200,000. 13.67% of the stock is owned by institutional investors.

Koninklijke Philips Trading Up 1.9 %

Shares of Koninklijke Philips stock traded up $0.52 during trading on Friday, hitting $27.98. 1,058,001 shares of the company were exchanged, compared to its average volume of 1,194,247. The firm has a market capitalization of $25.98 billion, a P/E ratio of -29.20, a price-to-earnings-growth ratio of 1.19 and a beta of 0.75. Koninklijke Philips has a 1-year low of $17.75 and a 1-year high of $29.44. The firm's fifty day moving average price is $22.27 and its 200 day moving average price is $21.70. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.20 and a quick ratio of 0.78.

Koninklijke Philips Cuts Dividend

The business also recently announced an annual dividend, which was paid on Thursday, May 9th. Stockholders of record on Friday, May 10th were given a dividend of $0.9154 per share. The ex-dividend date was Thursday, May 9th. This represents a dividend yield of 3.5%. Koninklijke Philips's payout ratio is currently -95.83%.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on PHG shares. UBS Group upgraded Koninklijke Philips from a "sell" rating to a "neutral" rating in a research report on Tuesday, April 30th. StockNews.com lowered Koninklijke Philips from a "buy" rating to a "hold" rating in a research report on Thursday. Sanford C. Bernstein upgraded Koninklijke Philips from a "market perform" rating to an "outperform" rating in a research report on Monday. JPMorgan Chase & Co. upgraded Koninklijke Philips from an "underweight" rating to a "neutral" rating in a research report on Tuesday, April 30th. Finally, BNP Paribas upgraded Koninklijke Philips from an "underperform" rating to a "neutral" rating in a research report on Tuesday, May 7th. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $19.00.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.